baber/WOPTO huggingface dataset:
Patent AU-2006337680-B2 (AU)
Title: Return spring assembly for a lock mechanism
Inventor: ZIMMER TODD C
IPC: E05C19/00
Filed: 2006-11-02
Granted: 2012-05-24
Abstract: A return spring assembly for returning a handle to the horizontal orientation includes a spring housing (12) having an outer flange that contacts an outer surface of a door around a perimeter of a bored opening and an inner portion with a curved section that securely supports a latchbolt lock mechanism when an identical return spring assembly is installed on an opposite side of the door. A spring (40) is driven by two spring drivers operating with a lost motion connection to the handle spindle to alternately compress the spring from opposite directions as the handle is rotated in opposite directions. The spring is positioned to not interfere with a linkage extending out from the latchbolt lock mechanism.
Patent AU-2007212002-B2 (AU)
Title: Bioengineered tissue constructs and cardiac uses thereof
Inventor: BILBO PATRICK R
IPC: A61F2/04
Filed: 2007-02-07
Granted: 2013-05-16
Abstract: Cultured tissue constructs comprising cultured cells and endogenously produced extracellular matrix components without the requirement of exogenous matrix components or network support or scaffold members. Some tissue constructs of the invention are comprised of multiple cell layers or more than one cell type. The tissue constructs of the invention have morphological features and functions similar to tissues their cells are derived and their strength makes them easily handleable. Preferred cultured tissue constructs of the invention are prepared in defined media, that is, without the addition of chemically undefined components. These tissue constructs are used to repair cardiac tissues.
Patent AU-2007229410-B2 (AU)
Title: Support for chest compression system
Inventor: HANSEN FREDERIK
IPC: A61H31/00
Filed: 2007-10-19
Granted: 2013-05-16
Abstract: The invention relates to a support for a chest compression system comprising a back plate, a front part and a side part, characterised in that the front part comprises a seat for a compression member and that the side part is adapted to provide 5 adjustable spacing between the seat and the back plate. The invention relates also to a chest compression system comprising such a support. d FIGURE 1 13 10 FIGURE 2 -- FIGURE 3 1213 10FIGURE 4
Patent AU-2007243475-B2 (AU)
Title: Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in miR155 transgenic mice
Inventor: CROCE CARLO M
IPC: A01K67/027
Filed: 2007-04-24
Granted: 2013-02-07
Abstract: A transgenic non-human animal, such as a mouse, has a genome that include a nucleic acid construct having at least one transcriptional regulatory sequence capable of directing expression in B cells of the animal, wherein the transcriptional regulatory sequence is operably linked to a nucleic acid encoding a miR155 gene product. A method of testing the therapeutic efficacy of an agent in treating or preventing a lymphoproliferative condition includes assessing the effect(s) of the agent on a transgenic non-human animal.
Patent AU-2007286787-B2 (AU)
Title: Ultrasonic treatment of glaucoma
Inventor: SCHWARTZ DONALD N
IPC: A61N7/00
Filed: 2007-08-21
Granted: 2012-09-20
Abstract: A method of treating glaucoma is described herein. The method includes the steps of providing an ultrasonic device that emits ultrasonic energy, holding the ultrasonic instrument at a location external to the trabecular meshwork, transmitting the ultrasonic energy at a frequency to a desired location for a predetermined time, dislodging material built up in the trabecular meshwork, and generating heat that initiates biochemical changes in the eye.
Patent AU-2007304601-B2 (AU)
Title: Display arrangement
Inventor: GOPFERT CHRISTIN
IPC: A47B96/14
Filed: 2007-09-25
Granted: 2010-11-18
Abstract: A display arrangement includes at least one profile, at least one essentially horizontally oriented planar rack element and at least one bracket element. The profile has at least one central web having two parallel inner flanges. The at least one profile can be oriented vertically, and the bracket element may be formed from a top part and a bottom part which can be drawn against one another by at least one tensioning screw. The top part and/or the bottom part are/is provided with clamping rails and/or clamping-rail segments which can be connected in a force fitting and releasable manner to the inner flanges by being plugged thereon, it being possible for each of the at least one rack element to be fixed in a force-fitting manner between the tensioning surfaces of a bracket element by the tensioning screw or of the tensioning screws being tightened.
Patent AU-2007335184-B2 (AU)
Title: A multiple valve assembly for reducing water loss from a leak
Inventor: CLAPPISON PETER
IPC: F17D5/02
Filed: 2007-12-21
Granted: 2012-12-20
Abstract: A valve assembly for reducing water loss from a leak from a water device. The valve assembly includes a first passage through which water flows from a water source to the water device and a second passage through which water flows from the water device. A first valve is in fluid communication with the first passage and the second passage. The first valve is operable for obstructing the first passage in response to a change in pressure differential between water in the first passage and water in the second passage resulting from a leak of water from the water device. The valve assembly also includes a second valve in fluid communication with the first passage. The second valve is responsive to the obstruction of the first passage to close the first passage and thereby stop water from flowing from the water source to the water device.
Patent AU-2008218463-B2 (AU)
Title: Peptide vaccines for cancers expressing tumor-associated antigens
Inventor: TSUNODA TAKUYA
IPC: C07K11/00
Filed: 2008-02-21
Granted: 2013-01-17
Abstract: The present invention provides peptides having an amino acid sequence as set forth in SEQ ID NO: SEQ ID NO: 19, 22, 30, 34, 344, 358, 41, 44, 46, 48, 78, 376, 379, 80, 100, 101, 110, 111, 387, 112, 394, 114, 116, 117, 121, 395, 133, 135, 137, 426, 174, 178, 186, 194, 196, 202, 210, 213, 214, 217, 223, 227, 228, 233, 254, 271, 272 or 288, as well as peptides having the above-mentioned amino acid sequences in which 1, 2, or several (e.g., up to 5) amino acids are substituted, deleted, or added, provided the peptides possess cytotoxic T cell inducibility. The present invention also provides drugs for treating or preventing a disease associated with over-expression of the CDH3, EPHA4, ECT2, HIG2, INHBB, KIF20A, KNTC2, TTK and/or URLC10, e.g. cancers containing as an active ingredient one or more of these peptides. The peptides of the present invention find further utility as vaccines.
Patent AU-2008228011-B2 (AU)
Title: Pilot valve for a pressure reducing valve
Inventor: BURROWS ANDREW ROLAND
IPC: G05D16/20
Filed: 2008-03-20
Granted: 2012-02-16
Abstract: A pilot valve (2) for controlling operation of a hydraulically-actuated pressure reducing valve, the pilot valve including a housing (4), and a first valve member (15) mounted in the housing for longitudinal movement along an axis relative to the housing and to a second valve member (22) in response to the outlet pressure of the pressure reducing valve. The first valve member is provided with an aperture (20) and the second valve member comprises a closure portion which varies the effective flow cross section of the aperture in accordance with relative longitudinal movement between the first and second valve members. An adjuster (26) controls the relative rotational position of the first and second valve members, the closure portion having a profile such that relative rotation between the first and second valve members causes the closure portion to vary the effective flow cross section of the aperture (20).
Patent AU-2008246386-B2 (AU)
Title: Slicing device
Inventor: AKESSON ELISABET
IPC: C12N5/00
Filed: 2008-04-30
Granted: 2013-09-12
Abstract: The invention relates to a biological microglia comprising at least two pores having a size adopted to allow cells, cell aggregates, tissue or other biological material to pass through said pores, and one or several slicing beams separating said pores from each other, wherein biological material is split/sliced/cleaved into at least two parts when passing said microgrid, a slicing device, an apparatus comprising said slicing device as well as the use of said microgrid, slicing device and apparatus.
Patent AU-2008248382-B2 (AU)
Title: Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders, or attention deficit disorders
Inventor: PEDDER SIMON
IPC: A61K31/198
Filed: 2008-05-07
Granted: 2013-07-18
Abstract: The present invention provides pharmaceutical compositions comprising droxidopa alone, or in combination with one or more further active ingredients, for the treatment of conditions, such as mood disorders, sleep disorders, or attention deficit disorders. In certain embodiments, the compositions useful in the methods of the invention comprise droxidopa and a compound selected from the group consisting of DOPA decarboxylase inhibiting compounds, catechol-0-methyltransferase inhibiting compounds, cholinesterase inhibiting compounds, monoamine oxidase inhibiting compounds, norepinephrine reuptake inhibiting compounds, selective serotonin reuptake inhibiting compounds, tricyclic antidepressant compounds, serotonin norepinephrine reuptake inhibiting compounds, norepinephrine dopamine reuptake inhibiting compound, noradrenergic and specific serotonergic antidepressants, and combinations thereof. The inventive compositions are particularly useful in the treatment of depression, narcolepsy, insomnia, and Attention Deficit/Hyperactivity Disorder (AD/HD).
Patent AU-2008284664-B2 (AU)
Title: Baculoviral vectors with a dual vertebrate and baculovirus promoter controlling an immunogenic fusion gene
Inventor: MIZUKOSHI MASAMI
IPC: A61K39/145
Filed: 2008-08-06
Granted: 2014-05-15
Abstract: The present invention provides a novel transfer vector and a recombinant baculovirus; methods for the production thereof; and pharmaceuticals containing the recombinant baculovirus as an active ingredient, which are useful as preventive or therapeutic drugs for infectious diseases such as malaria and influenza. More specifically, the invention provides a recombinant transfer vector capable of expressing a foreign gene fused to a virus gene under the control of a dual promoter; a recombinant baculovirus; methods for the production thereof; and pharmaceuticals containing the recombinant baculovirus as an active ingredient.
Patent AU-2008307636-B2 (AU)
Title: Noninvasive fluid density and viscosity measurement
Inventor: SINHA DIPEN N
IPC: G01F17/00
Filed: 2008-09-29
Granted: 2014-10-30
Abstract: The noninvasively measurement of the density and viscosity of static or flowing fluids in a section of pipe such that the pipe performs as the sensing apparatus, is described. Measurement of a suitable structural vibration resonance frequency of the pipe and the width of this resonance permits the density and viscosity to be determined, respectively. The viscosity may also be measured by monitoring the decay in time of a vibration resonance in the pipe.
Patent AU-2008311974-B2 (AU)
Title: Calcium receptor modulating agents
Inventor: KELLY MICHAEL G
IPC: A61K31/40
Filed: 2008-10-15
Granted: 2013-11-21
Abstract: The present invention relates generally to novel calcimimetic compounds and pharmaceutical compositions comprising them. The invention also relates to methods of treating of diseases or disorders related to the function of the calcium sensing receptor using the compounds represented in Formula I.
Patent AU-2008316313-B2 (AU)
Title: A method of diagnosing neoplasms - II
Inventor: LOCKETT TREVOR JOHN
IPC: C12Q1/68
Filed: 2008-10-23
Granted: 2015-04-16
Abstract: The present invention relates generally to nucleic acid molecules in respect of which changes to the DNA or to the RNA or protein expression profiles are indicative of the onset, predisposition to the onset and/or progression of a neoplasm. More particularly, the present invention is directed to nucleic acid molecules in respect of which changes to the DNA or to the RNA or protein expression profiles are indicative of the onset and/or progression of a large intestine neoplasm, such as an adenoma or an adenocarcinoma. The DNA or the expression profiles of the present invention are useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenocarcinomas. Accordingly, in a related aspect the present invention is directed to a method of screening a subject for the onset, predisposition to the onset and/or progression of a neoplasm by screening for modulation in the DNA or the RNA or protein expression profile of one or more nucleic acid molecule markers.
Patent AU-2009210305-B2 (AU)
Title: Process for the production of fermented beverages
Inventor: KOWALCZYK JORG
IPC: A23L27/30
Filed: 2009-01-21
Granted: 2013-05-09
Abstract: The present invention relates to a method for the continuous production of fermented, trehalulose-comprising beverages, particularly ready-to-drink beverages or beverage concentrates.
Patent AU-2009210660-B2 (AU)
Title: Biodiesel purification by a continuous regenerable adsorbent process
Inventor: MUNSON JAMES R
IPC: B01D15/00
Filed: 2009-02-06
Granted: 2014-07-24
Abstract: A process for the continuous purification of biodiesel (fatty acid alkyl esters (FAAE)) is described using an adsorbent The adsorbent is contained in a column system and is regenerated for reuse multiple times The process employs an adsorbent such as, carbon, silica, clay, zeolite or a metal silicate contained in a column to remove the impurities from fatty acid alkyl esters (FAAE) or crude biodiesel in a continuous process The crude biodiesel is contacted with an adsorbent packed into one or more columns to remove impurities such as soaps, metals, free glycerin, and sterol glucosides. The resulting finished biodiesel exiting the column(s) is ready for the methanol recovery process Once the adsorbent no longer removes the desired amount of impurities, it is regenerated for reuse The solvent used for the regeneration process is reclaimed and reused by recycling it back to the transesterification reaction.
Patent AU-2009221455-B2 (AU)
Title: Connecting piece for a clamping connector
Inventor: BONHAG EHRENFRIED
IPC: F16L33/22
Filed: 2009-03-05
Granted: 2012-08-16
Abstract: The invention relates to a polymer connecting piece (1) for a clamping connector for pipes and/or tubes (2), made of a polymer material and comprising at least two pipe/tube connecting elements (3). At least one connection element (3) comprises a plug-in area (5) that is provided with peripheral ribs (4, 4a, 4b) and that is used to slide open the end of a pipe and/or tube (2a), to which respectively one flange projection (6) connects. At least one tooth-shaped elevation (7) is arranged on the side of the flange projection (6) opposite the peripheral ribs (4, 4a, 4b). The invention also relates to a clamping connector for pipes and/or tubes (2) made of a polymer material and comprising the inventive polymer connecting piece (1) and a sliding sleeve (10) that can be moved axially in relation to the pipe/tube axis. The inventive polymer connecting piece (1) allows less material to be used in relation to the claimed connecting piece and prevents the flange projection (6) from being damaged during the production of said connection.
Patent AU-2009228535-B2 (AU)
Title: Interface device and junction box for a HTSC degaussing coil
Inventor: MAGUIRE JAMES F
IPC: H01R4/68
Filed: 2009-03-18
Granted: 2013-05-16
Abstract: A junction box (14) is provided which allows serial connection of the individual conductors (3) of at least one high temperature superconductor (HTS) wire bundle (2). The junction box includes an electrical interface device (3) disposed within a junction box housing. The interface device is configured receive both ends of each conductor of each HTS wire bundle, and to provide a superconductive electrical connection between respective first ends of conductors to respective second ends of other wire bundle conductors to form at least one superconductive multi-turn electromagnetic winding.
Patent AU-2009239471-B2 (AU)
Title: Quinoline or isoquinoline substituted P2X7 antagonists
Inventor: WIENER DANIELLE
IPC: C07D413/14
Filed: 2009-04-21
Granted: 2013-01-24
Abstract: The present invention is related to novel compounds of formula (I) having P2X7 antagonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and their use in the treatment or prophylaxis of diseases associated with P2X7 receptor activity in animals, in particular humans. (I)
Patent AU-2009289238-B2 (AU)
Title: Novel inhibitors
Inventor: ALMSTETTER MICHAEL
IPC: A61K31/4178
Filed: 2009-09-04
Granted: 2014-09-04
Abstract: Compounds of general formula (I): wherein R
Patent AU-2009291162-B2 (AU)
Title: Universal infrastructure for chemical processes
Inventor: LANG JURGEN ERWIN
IPC: B01J19/00
Filed: 2009-05-14
Granted: 2015-08-06
Abstract: The invention relates to an installation for carrying out chemical processes, at least comprising means for directly carrying out the conversion in the form of means for the development of products and/or in the form of at least one reactor for the continuous industrial production of products, devices for receiving and/or providing reactants and/or products as well as devices for controlling the conversion, which are combined to form a single integrated and transportable functional unit serving as an infrastructure, preferably in the form of a standard transport container.
Patent AU-2009297512-B2 (AU)
Title: Mobile station
Inventor: TANAKA ITSUMA
IPC: H04W60/04
Filed: 2009-09-25
Granted: 2013-10-31
Abstract: A mobile station UE is configured as follows.  Upon detection of a failure in a radio link established between the mobile station UE and a radio base station eNB or upon detection of a cell to be position-registered by a cell selection process, an AS function reports the detection to a NAS function.  In response to the report, the NAS function transmits a position registration request signal to an exchange station MME.
Patent AU-2009303763-B2 (AU)
Title: Use of silicon-containing polymers for improved flocculation of solids in processes for the production of alumina from bauxite
Inventor: DAVIS MATTHEW J
IPC: C01F7/0653
Filed: 2009-09-22
Granted: 2014-04-17
Abstract: The suspended solids content of a process stream in a process for digesting bauxite ore to produce alumina is reduced by contacting the stream with silicon- containing polymers.
Patent AU-2009313682-B2 (AU)
Title: Compact dunnage conversion machine
Inventor: DEMERS RAIMOND
IPC: B31B50/59
Filed: 2009-11-17
Granted: 2015-12-24
Abstract: A dunnage conversion machine includes a conversion assembly having a pair of rotating members (60) to feed stock material along a path between the rotating members mounted for rotation about respective axes to feed stock material along a path between the rotating members, and a chute (112) that bounds the path between the rotating members. One of the rotating members and a portion of the chute are mounted for common movement toward and away from the other rotating member and another portion of the chute (114). The floating rotating member and floating portion of the chute are part of a subassembly that can be removed from the conversion assembly as a unit, separate from another portion of the chute and the other rotating member.
Patent AU-2009331955-B2 (AU)
Title: Biomarkers for inhibitors with anti-angiogenic activity
Inventor: BEHRENS JOYCE
IPC: G01N33/574
Filed: 2009-12-14
Granted: 2015-09-24
Abstract: The invention relates to a method for assessing the effect of integrin inhibitors and small molecule ATP site directed multi kinase inhibitors on angiogenesis by the use of certain identified biomarkers. This method is notably beneficial for the determination of the efficacy of integrin inhibitors and small molecule ATP site directed multi-kinase inhibitors mainly used for the treatment of angiogenesis associated diseases such as cancer. Especially, the invention relates to biomarkers linked to angiogenesis that are preferably accessible in body fluids and therefore allow analysis of target modulation in a non-invasive way. The use of said biomarkers for the screening of compounds with integrin-inhibitory activity is also disclosed.
Patent AU-2009334831-B2 (AU)
Title: Odor controlled personal care compositions containing hydroxypropyl trialkylammonium salts
Inventor: YANG LIN
IPC: A61K8/26
Filed: 2009-12-24
Granted: 2012-05-24
Abstract: A personal care composition is provided which includes from 0.1 to 30% of a dihydroxypropyltri(C-C alkyl) ammonium salt by weight of the composition; from 0.0001 to 0.005% of a tri(C-C alkyl) amine or protonated form thereof by weight of the ammonium salt; from 0.002 to 15% of an aluminum salt by weight of the composition; and a cosmetically acceptable carrier wherein the composition has a pH ranging from 5.5 to 6.9. Unpleasant amine odor from trialkyl amines which arise from the dihydroxypropyltri(C-C alkyl) ammonium salts is suppressed by the aluminum salt and by careful control of pH conditions.
Patent AU-2009346233-B2 (AU)
Title: ECR particle beam source apparatus, system and method
Inventor: ROSENTHAL GLENN B
IPC: H01J37/08
Filed: 2009-07-16
Granted: 2016-01-07
Abstract: An ion source (10) is disclosed including: a chamber (30) disposed about a longitudinal axis (A) and containing a gas, a magnetic confinement system (36, 38) configured to produce a magnetic field in a confinement region within the chamber, an electron cyclotron resonance driver (44) which produces a time varying electric field which drives the cyclotron motion of electrons located within the confinement region, the driven electrons interacting with the gas to form a confined plasma (57). During operation, the magnetic confinement system confines the plasma in the confinement region such that a portion of atoms in the plasma experience multiple ionizing interactions with the driven electrons to form multiply ionized ions having a selected final ionization state.
Patent AU-2009350650-B2 (AU)
Title: Signal transmission processing method and apparatus and distributed base station
Inventor: TAN JINGXIN
IPC: H04B10/29
Filed: 2009-07-27
Granted: 2014-01-09
Abstract: A signal transmission processing method and device, and a distributed base station are provided. The method includes: obtaining at least one path distributed base station interface signal (101); executing optical transport network electrical layer multiplexing processing to the at least one path distributed base station interface signal obtained (102); executing electro-optical conversion to the signal, processed by the optical transport network electrical layer multiplexing, in order to generate one path optical signal, and transmitting it (103). The device includes: an obtaining module, for obtaining at least one path distributed base station interface signal; a multiplexing processing module, for executing optical transport network electrical layer multiplexing processing to the at least one path distributed base station interface signal obtained; a first transmitting module, for executing electro-optical conversion to the signal, processed by the optical transport network electrical layer multiplexing, in order to generate one path optical signal, and transmitting it. The signal transmission processing method and device, and the distributed base station can multiplex multi-paths signals into one path optical signal, and enhance signal transmission efficiency.